Cargando…
Protein kinase C delta mediates Pasireotide effects in an ACTH-secreting pituitary tumor cell line
PURPOSE: Clinical control of corticotroph tumors is difficult to achieve since they usually persist or relapse after surgery. Pasireotide is approved to treat patients with Cushing’s disease for whom surgical therapy is not an option. However, Pasireotide seems to be effective only in a sub-set of p...
Autores principales: | Gentilin, E., Borges De Souza, P., Ambrosio, M. R., Bondanelli, M., Gagliardi, I., Zatelli, M. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632222/ https://www.ncbi.nlm.nih.gov/pubmed/37233978 http://dx.doi.org/10.1007/s40618-023-02117-0 |
Ejemplares similares
-
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase Cδ
por: Gentilin, Erica, et al.
Publicado: (2013) -
Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis
por: Mondin, Alessandro, et al.
Publicado: (2022) -
ACTH Secreting Pituitary Tumours
por: Nabarro, J. D. N.
Publicado: (1977) -
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs
por: Treppiedi, Donatella, et al.
Publicado: (2022) -
Cushing’s Disease as a Result of Two ACTH-Secreting Pituitary Tumors
por: Mathai, Christine, et al.
Publicado: (2020)